1002 Kaynaklar-Son

EK-1: KAYNAKLAR
Bu bölümde, proje önerisinde yararlanılan kaynakların listesi http://www.tubitak.gov.tr/ardeb-kaynakca

sayfasındaki açıklamalara uygun olarak verilmeli ve bu kaynaklara metin içerisinde atıf yapılmalıdır
Burton C., Ma Y. 2018. "Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics:
Achievements and New Challenges", Curr. Med. Chem., 26, 5–28.
Connolly S.J., Gent M., Roberts R.S., Dorian P., Green M.S., Klein G.J., Mitchell L.B., Sheldon R.S., Roy D. 1993.
"On behalf of the CIDS Co-Investigators, Canadian Implantable Defibrillator Study (CIDS): Study design and
organization", Am. J. Cardiol., 72, 1297–1303.
Dunn W.B. 2008. "Current trends and future requirements for the mass spectrometric investigation of microbial,
mammalian and plant metabolomes", Phys. Biol., 5.
Golcuk E., Yalin K., Aksu T., Aksu S.K., Bilge A.K., Adalet K. 2016. "Peri-infarction zone as a risk marker for patie
nts with postm yocardial infarction", Am. J. Med. Sci., 351, 452–458.
Goldberger J.J., Basu A., Boineau R., Buxton A.E., Cain M.E., Canty J.M., Chen P.S., Chugh S.S., Costantini O.,
Exner D. V., Kadish A.H., Lee B., Lloyd-Jones D., Moss A.J., Myerburg R.J., Olgin J.E., Passman R., Stevenson
W.G., Tomaselli G.F., Zareba W., Zipes D.P., Zoloth L. 2014. "Risk stratification for sudden cardiac death: A plan
for the future", Circulation, 129, 516–526.
Griffin J.L., Williams H.J., Sang E., Nicholson J.K. 2001. "Abnormal lipid profile of dystrophic cardiac tissue as
demonstrated by one- and two-dimensional magic-angle spinning 1H NMR spectroscopy", Magn. Reson. Med.,
46, 249–255.
Heather L.C., Wang X., West J.A., Griffin J.L. 2013. "A practical guide to metabolomic profiling as a discovery tool
for human heart disease", J. Mol. Cell. Cardiol., 55, 2–11.
Kell D.B., Oliver S.G. 2016. "The metabolome 18 years on: a concept comes of age", Metabolomics., 12, 1–8.
Mann I., Kaura A., Scott P.A. 2014. "How to better identify patients that do not benefit from prophylactic ICD
therapy?", J. Atr. Fibrillation., 7, 61–65.
Markley J. L., Brüschweiler R., Edison A. S., Eghbalnia H. R., Powers, R., Raftery D., & Wishart, D. S.
2017."Thfuture of NMR-based metabolomics". Current opinion in biotechnology, 43, 34–40.
Moss A.J. 2003. "MADIT-I and MADIT-II", J. Cardiovasc. Electrophysiol., 14, 96–98.
Oliver S.G., Winson M.K., Kell D.B., Baganz F. 1998. "Systematic functional analysis of the yeast genome",
Trends Biotechnol., 16, 373–378.
Osman J., Tan S.C., Lee P.Y., Low T.Y., Jamal R. 2019. "Sudden Cardiac Death ( SCD ) – risk stratification and
prediction with molecular biomarkers", 8, 1–12.
Priori S.G., Blomstrom-Lundqvist C., Mazzanti A., Bloma N., Borggrefe M., Camm J., Elliott P.M., Fitzsimons D.,
Hatala R., Hindricks G., Kirchhof P., Kjeldsen K., Kuck K.H., Hernandez-Madrid A., Nikolaou N., Norekval T.M.,
Spaulding C., Van Veldhuisen D.J., Kolh P., Lip G.Y.H., Agewall S., Barón-Esquivias G., Boriani G., Budts W.,
Bueno H., Capodanno D., Carerj S., Crespo-Leiro M.G., Czerny M., Deaton C., Dobrev D., Erol Ç., Galderisi M.,
Gorenek B., Kriebel T., Lambiase P., Lancellotti P., Lane D.A., Lang I., Manolis A.J., Morais J., Moreno J., Piepoli
M.F., Rutten F.H., Sredniawa B., Zamorano J.L., Zannad F., Aboyans V., Achenbach S., Badimon L.,
Baumgartner H., Bax J.J., Dean V., Fitzsimons D., Gaemperli O., Nihoyannopoulos P., Ponikowski P., Roffi M.,
Torbicki A., Vaz Carneiro A., Windecker S., Piruzyan A., Roithinger F.X., Mairesse G.H., Goronja B., Shalganov
T., Shalganov D., Antoniades L., Kautzner J., Larsen J.M., Aboulmaaty M., Kampus P., Hedman A., Kamcevska-
Dobrkovic L., Piot O., Etsadashvili K., Eckardt L., Deftereos S., Gellér L., Gizurarson S., Keane D., Haim M., P.,
Abdrakhmanov A., Mirrakhimov A., Kalejs O., Ben Lamin H., Marinskis G., Groben L., Sammut M., Raducan A.,
Chaib A., Tande P.M., Lenarczyk R., Morgado F.B., Vatasescu R., Mikhaylov E.N., Hlivak P., Arenal A., Jensen-
Urstad M., Sticherling C., Zeppenfeld K., Chettaoui R., Demir M., Duncan E., Parkhomenko A. 2015. "ESC
Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac
death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden
Cardiac Death of the Europea", Eur. Heart J., 36, 2793-2867l.
Sanders G.D., Hlatky M.A., Owens D.K. 2005. "Cost-Effectiveness of Implantable Cardioverter–Defibrillators", N
Engl J Med, 353, 1471–1480.
1002BF-01 Güncelleme Tarihi: 30/07/2018
1
Savolainen O., Fagerberg B., Lind M.V., Sandberg A.S., Ross A.B., Bergström G. 2017. "Biomarkers for predicting
type 2 diabetes development—Can metabolomics improve on existing biomarkers?", PLoS One., 12, 1–11.
Shomanova Z., Ohnewein B., Schernthaner C., Höfer K., Pogoda C.A., Frommeyer G., Wernly B., Brandt M.C.,
Dieplinger A.-M., Reinecke H., Hoppe U.C., Strohmer B., Pistulli R., Motloch L.J. 2020. "Classic and Novel
Biomarkers as Potential Predictors of Ventricular Arrhythmias and Sudden Cardiac Death", J. Clin. Med. 9, 578.
Tian J., Smith M.F., Chinnadurai P., Dilsizian V., Turgeman A., Abbo A., Gajera K., Xu C., Plotnick D., Plotnick R.,
Saba M., Shorofsky S., Dickfeld T. 2009. "Clinical application of PET-CT fusion imaging for three-dimensional
myocardial scar and left ventricular anatomy during ventricular tachycardia ablation", J. Cardiovasc.
Electrophysiol., 20, 597–604.
Trivedi D.K., Hollywood K.A., Goodacre R. 2017. "Metabolomics for the masses: The future of metabolomics in a
personalized world", New Horizons Transl. Med., 3, 294–305.
Tung R., Zimetbaum P., Josephson M.E. 2008. "A Critical Appraisal of Implantable Cardioverter-Defibrillator
Therapy for the Prevention of Sudden Cardiac Death", J. Am. Coll. Cardiol., 52, 1111–1121.
Wang X., Wang D., X. Zhang Yu, G., Wu J., Zhu G., Su R., Lv J. 2016. "Non-targeted metabolomics identified a
common metabolic signature of lethal ventricular tachyarrhythmia (LVTA) in two rat models", Mol. Biosyst., 12,
2213–2223.
Wishart D.S. 2016. "Emerging applications of metabolomics in drug discovery and precision medicine", Nat. Rev.
Drug Discov., 15, 473–484.
Wu J., Wu Q., Wang Di., Kong J., Dai W., Wang X., Yu X. 2017. "Common lipid features of lethal ventricular
tarchyarrhythmias (LVTAs) induced by myocardial infarction and myocardial ion channel diseases", Sci. Rep., 7,
1–10.
Yalin K., Golcuk E., Buyukbayrak H., Yilmaz R., Arslan M., Dursun M., Bilge A.K., Adalet K. 2014. "Infarct
characteristics by CMR identifies substrate for monomorphic VT in Post-MI patients with relatively preserved
systolic function and ns-vt", PACE - Pacing Clin. Electrophysiol., 37 , 447–453.
Yu X., White L.T., Alpert N.M., Lewandowski E.D. 1996. "Subcellular metabolite transport and carbon isotope
kinetics in the intramyocardial glutamate pool", Biochemistry., 35, 6963–6968.
1002BF-01 Güncelleme Tarihi: 30/07/2018

1002 Kaynaklar-Son

Uploaded by

Copyright:

Available Formats

1002 Kaynaklar-Son

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

1002 Kaynaklar-Son

Uploaded by

Copyright:

Available Formats

EK-1: KAYNAKLAR

Bu bölümde, proje önerisinde yararlanılan kaynakların listesi http://www.tubitak.gov.tr/ardeb-kaynakca

1002BF-01 Güncelleme Tarihi: 30/07/2018

1002BF-01 Güncelleme Tarihi: 30/07/2018

You might also like